PURPOSE: To evaluate a newly implemented infectious disease (ID) consultation service in terms of patient care, outcome and antibiotic prescription and to describe factors influencing adherence to recommendations. METHODS: Data from consultations during the first 6 months of the ID consultation program were collected and evaluated. Consultation requests, diagnostic results, treatment outcomes and antibiotic recommendations were categorised. Diagnostic and therapeutic recommendations were assessed and rated for adherence and outcome. Statistical analysis was performed to identify factors influencing adherence and treatment outcome. RESULTS: A total of 251 consultations were assessed. In most cases, ID specialists were asked for further advice regarding a previously initiated anti-infective treatment (N = 131, 52 %). In 54 of 195 (28 %) first consultations, the ID specialist proposed a differential diagnosis that differed from that of the working diagnoses submitted with the consultation request, and which was subsequently confirmed in 80 % of these cases. Diagnostic and therapeutic recommendations were made in 190 (76 %) and 240 (96 %) of the consultations, respectively. A change in the current treatment was recommended in 66 % of consultations; 37 % of recommendations were cost-saving and 26 % were cost-neutral. Compliance with diagnostic and therapeutic recommendations was rated as good by pre-specified criteria in 65 and 86 % of consultations, respectively. Treatment outcome was correlated with adherence to diagnostic recommendations (P = 0.012). Twenty-nine patients (16 %) died during the same hospital stay. CONCLUSION: Infectious disease consultations may help to establish the correct diagnosis, resulting in the appropriate treatment being provided to a severely sick patient population. Treatment outcome was improved in cases of good diagnostic adherence to the recommendations of the ID specialist.
PURPOSE: To evaluate a newly implemented infectious disease (ID) consultation service in terms of patient care, outcome and antibiotic prescription and to describe factors influencing adherence to recommendations. METHODS: Data from consultations during the first 6 months of the ID consultation program were collected and evaluated. Consultation requests, diagnostic results, treatment outcomes and antibiotic recommendations were categorised. Diagnostic and therapeutic recommendations were assessed and rated for adherence and outcome. Statistical analysis was performed to identify factors influencing adherence and treatment outcome. RESULTS: A total of 251 consultations were assessed. In most cases, ID specialists were asked for further advice regarding a previously initiated anti-infective treatment (N = 131, 52 %). In 54 of 195 (28 %) first consultations, the ID specialist proposed a differential diagnosis that differed from that of the working diagnoses submitted with the consultation request, and which was subsequently confirmed in 80 % of these cases. Diagnostic and therapeutic recommendations were made in 190 (76 %) and 240 (96 %) of the consultations, respectively. A change in the current treatment was recommended in 66 % of consultations; 37 % of recommendations were cost-saving and 26 % were cost-neutral. Compliance with diagnostic and therapeutic recommendations was rated as good by pre-specified criteria in 65 and 86 % of consultations, respectively. Treatment outcome was correlated with adherence to diagnostic recommendations (P = 0.012). Twenty-nine patients (16 %) died during the same hospital stay. CONCLUSION:Infectious disease consultations may help to establish the correct diagnosis, resulting in the appropriate treatment being provided to a severely sick patient population. Treatment outcome was improved in cases of good diagnostic adherence to the recommendations of the ID specialist.
Authors: Andrew F Shorr; Scott T Micek; Emily C Welch; Joshua A Doherty; Richard M Reichley; Marin H Kollef Journal: Crit Care Med Date: 2011-01 Impact factor: 7.598
Authors: J O Robinson; S Pozzi-Langhi; M Phillips; J C Pearson; K J Christiansen; G W Coombs; R J Murray Journal: Eur J Clin Microbiol Infect Dis Date: 2012-03-03 Impact factor: 3.267
Authors: J Gómez; S J Conde Cavero; J L Hernández Cardona; M L Núñez; J Ruiz Gómez; M Canteras; M Valdés Journal: J Antimicrob Chemother Date: 1996-08 Impact factor: 5.790
Authors: Timothy C Jenkins; Connie S Price; Allison L Sabel; Philip S Mehler; William J Burman Journal: Clin Infect Dis Date: 2008-04-01 Impact factor: 9.079
Authors: Siegbert Rieg; Gabriele Peyerl-Hoffmann; Katja de With; Christian Theilacker; Dirk Wagner; Johannes Hübner; Markus Dettenkofer; Achim Kaasch; Harald Seifert; Christian Schneider; Winfried V Kern Journal: J Infect Date: 2009-08-03 Impact factor: 6.072
Authors: Rüdiger VON Eisenhart-Rothe; Heinrich Maria Laurentius Mühlhofer; Christian Suren; Susanne Feihl; Christiane Querbach; Patrick Rämer; Florian Pohlig; Jakob Thurner; Rudolf Bernard; Dirk Busch Journal: In Vivo Date: 2019 Sep-Oct Impact factor: 2.155
Authors: Monica K Lieng; Magi S Aurora; Young Kang; Joseph M Kim; James P Marcin; Steven R Chan; Jamie L Mouzoon; Daniel J Tancredi; Michelle Parish; Alvaro D Gonzalez; Lorin Scher; Glen Xiong; Robert M McCarron; Peter Yellowlees Journal: Telemed J E Health Date: 2021-11-02 Impact factor: 5.033